Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.

Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page
- CheckyesterdayChange DetectedDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information about SL-701 for treating recurrent glioblastoma and the addition of a new revision number.SummaryDifference35%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 3, 2025.SummaryDifference0.2%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version release, moving from v2.14.2 to v2.14.3, and the last update date has changed from February 3, 2025, to March 25, 2025.SummaryDifference0.2%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.